Peptide Market Report

Europe Peptide Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 14, 2019
  • PAGES：157
  • REPORT CODE：GMM318909
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Peptide market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Peptide Market Segmentations:

    By Player:

    • Bachem

    • Xinbang

    • USVPeptides

    • PolyPeptide

    • JPT

    • ScinoPharm

    • Hybio

    • Thermofischer

    • CPC Scientific

    • Europe Pharmaceutical

    • GL Biochem

    • Lanthio Pharma

    • New England Peptide

    • Genscript

    • AnaSpec

    By Type:

    • Under 75%

    • 75% to 85%

    • Above 85%

    By End-User:

    • Commercial

    • Academic Research

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptide Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Peptide Market Size and Growth Rate of Under 75% from 2014 to 2026

    • 1.3.2 Europe Peptide Market Size and Growth Rate of 75% to 85% from 2014 to 2026

    • 1.3.3 Europe Peptide Market Size and Growth Rate of Above 85% from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Peptide Market Size and Growth Rate of Commercial from 2014 to 2026

    • 1.4.2 Europe Peptide Market Size and Growth Rate of Academic Research from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Peptide Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Peptide Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Peptide Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Peptide by Major Types

      • 3.4.1 Market Size and Growth Rate of Under 75%

      • 3.4.2 Market Size and Growth Rate of 75% to 85%

      • 3.4.3 Market Size and Growth Rate of Above 85%

    4 Segmentation of Peptide Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Peptide by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Peptide for Commercial

      • 4.4.2 Market Size and Growth Rate of Peptide for Academic Research

    5 Market Analysis by Major Regions

    • 5.1 Europe Peptide Production Analysis by Top Regions

    • 5.2 Europe Peptide Consumption Analysis by Top Regions

    • 5.3 Europe Peptide Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Peptide Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Peptide Production, Import, Consumption and Export Analysis

      • 5.3.3 France Peptide Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Peptide Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Peptide Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Peptide Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Peptide Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Peptide Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Peptide Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Peptide Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Peptide Production, Import, Consumption and Export Analysis

    6 Product Circulation of Peptide Market among Top Countries

    • 6.1 Top 5 Export Countries in Peptide Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Peptide Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Peptide Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Peptide Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Peptide Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Peptide Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Peptide Landscape Analysis

    • 7.1 Germany Peptide Landscape Analysis by Major Types

    • 7.2 Germany Peptide Landscape Analysis by Major End-Users

    8. UK Peptide Landscape Analysis

    • 8.1 UK Peptide Landscape Analysis by Major Types

    • 8.2 UK Peptide Landscape Analysis by Major End-Users

    9. France Peptide Landscape Analysis

    • 9.1 France Peptide Landscape Analysis by Major Types

    • 9.2 France Peptide Landscape Analysis by Major End-Users

    10. Italy Peptide Landscape Analysis

    • 10.1 Italy Peptide Landscape Analysis by Major Types

    • 10.2 Italy Peptide Landscape Analysis by Major End-Users

    11. Spain Peptide Landscape Analysis

    • 11.1 Spain Peptide Landscape Analysis by Major Types

    • 11.2 Spain Peptide Landscape Analysis by Major End-Users

    12. Poland Peptide Landscape Analysis

    • 12.1 Poland Peptide Landscape Analysis by Major Types

    • 12.2 Poland Peptide Landscape Analysis by Major End-Users

    13. Russia Peptide Landscape Analysis

    • 13.1 Russia Peptide Landscape Analysis by Major Types

    • 13.2 Russia Peptide Landscape Analysis by Major End-Users

    14. Switzerland Peptide Landscape Analysis

    • 14.1 Switzerland Peptide Landscape Analysis by Major Types

    • 14.2 Switzerland Peptide Landscape Analysis by Major End-Users

    15. Turkey Peptide Landscape Analysis

    • 15.1 Turkey Peptide Landscape Analysis by Major Types

    • 15.2 Turkey Peptide Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Landscape Analysis by Top Countries

      • 16.3.1 Denmark Peptide Market Volume and Growth Rate

      • 16.3.2 Finland Peptide Market Volume and Growth Rate

      • 16.3.3 Norway Peptide Market Volume and Growth Rate

      • 16.3.4 Sweden Peptide Market Volume and Growth Rate

      • 16.3.6 Iceland Peptide Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Peptide Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Peptide Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Peptide Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Peptide Landscape Analysis by Top Countries

      • 17.3.1 Belgium Peptide Market Volume and Growth Rate

      • 17.3.2 Netherlands Peptide Market Volume and Growth Rate

      • 17.3.3 Luxembourg Peptide Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Peptide Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Peptide Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Peptide Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Peptide Landscape Analysis by Top Countries

      • 18.3.1 Estonia Peptide Market Volume and Growth Rate

      • 18.3.2 Latvia Peptide Market Volume and Growth Rate

      • 18.3.3 Lithuania Peptide Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Bachem

      • 19.1.1 Bachem Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Xinbang

      • 19.2.1 Xinbang Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 USVPeptides

      • 19.3.1 USVPeptides Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 PolyPeptide

      • 19.4.1 PolyPeptide Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 JPT

      • 19.5.1 JPT Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 ScinoPharm

      • 19.6.1 ScinoPharm Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Hybio

      • 19.7.1 Hybio Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Thermofischer

      • 19.8.1 Thermofischer Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 CPC Scientific

      • 19.9.1 CPC Scientific Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Europe Pharmaceutical

      • 19.10.1 Europe Pharmaceutical Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 GL Biochem

      • 19.11.1 GL Biochem Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Lanthio Pharma

      • 19.12.1 Lanthio Pharma Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 New England Peptide

      • 19.13.1 New England Peptide Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Genscript

      • 19.14.1 Genscript Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 AnaSpec

      • 19.15.1 AnaSpec Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 70 Figures and 147 Tables)

    • Figure Product Picture

    • Figure Europe Peptide Market Size and Growth Rate of Under 75% from 2014 to 2026

    • Figure Europe Peptide Market Size and Growth Rate of 75% to 85% from 2014 to 2026

    • Figure Europe Peptide Market Size and Growth Rate of Above 85% from 2014 to 2026

    • Figure Europe Peptide Market Size and Growth Rate of Commercial from 2014 to 2026

    • Figure Europe Peptide Market Size and Growth Rate of Academic Research from 2014 to 2026

    • Figure Germany Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure UK Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure France Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Peptide Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Peptide Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Peptide

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Peptide by Different Types from 2014 to 2026

    • Table Consumption Share of Peptide by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Under 75%

    • Figure Market Size and Growth Rate of 75% to 85%

    • Figure Market Size and Growth Rate of Above 85%

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Peptide by Different End-Users from 2014 to 2026

    • Table Consumption Share of Peptide by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Commercial

    • Figure Market Size and Growth Rate of Academic Research

    • Table Europe Peptide Production by Major Regions

    • Table Europe Peptide Production Share by Major Regions

    • Figure Europe Peptide Production Share by Major Countries and Regions in 2014

    • Table Europe Peptide Consumption by Major Regions

    • Table Europe Peptide Consumption Share by Major Regions

    • Table Germany Peptide Production, Import, Consumption and Export Analysis

    • Table UK Peptide Production, Import, Consumption and Export Analysis

    • Table France Peptide Production, Import, Consumption and Export Analysis

    • Table Italy Peptide Production, Import, Consumption and Export Analysis

    • Table Spain Peptide Production, Import, Consumption and Export Analysis

    • Table Poland Peptide Production, Import, Consumption and Export Analysis

    • Table Russia Peptide Production, Import, Consumption and Export Analysis

    • Table Switzerland Peptide Production, Import, Consumption and Export Analysis

    • Table Turkey Peptide Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptide Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptide Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Peptide Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Peptide Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Peptide Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Peptide Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Peptide Consumption by Types from 2014 to 2026

    • Table Germany Peptide Consumption Share by Types from 2014 to 2026

    • Table Germany Peptide Consumption by End-Users from 2014 to 2026

    • Table Germany Peptide Consumption Share by End-Users from 2014 to 2026

    • Table UK Peptide Consumption by Types from 2014 to 2026

    • Table UK Peptide Consumption Share by Types from 2014 to 2026

    • Table UK Peptide Consumption by End-Users from 2014 to 2026

    • Table UK Peptide Consumption Share by End-Users from 2014 to 2026

    • Table France Peptide Consumption by Types from 2014 to 2026

    • Table France Peptide Consumption Share by Types from 2014 to 2026

    • Table France Peptide Consumption by End-Users from 2014 to 2026

    • Table France Peptide Consumption Share by End-Users from 2014 to 2026

    • Table Italy Peptide Consumption by Types from 2014 to 2026

    • Table Italy Peptide Consumption Share by Types from 2014 to 2026

    • Table Italy Peptide Consumption by End-Users from 2014 to 2026

    • Table Italy Peptide Consumption Share by End-Users from 2014 to 2026

    • Table Spain Peptide Consumption by Types from 2014 to 2026

    • Table Spain Peptide Consumption Share by Types from 2014 to 2026

    • Table Spain Peptide Consumption by End-Users from 2014 to 2026

    • Table Spain Peptide Consumption Share by End-Users from 2014 to 2026

    • Table Poland Peptide Consumption by Types from 2014 to 2026

    • Table Poland Peptide Consumption Share by Types from 2014 to 2026

    • Table Poland Peptide Consumption by End-Users from 2014 to 2026

    • Table Poland Peptide Consumption Share by End-Users from 2014 to 2026

    • Table Russia Peptide Consumption by Types from 2014 to 2026

    • Table Russia Peptide Consumption Share by Types from 2014 to 2026

    • Table Russia Peptide Consumption by End-Users from 2014 to 2026

    • Table Russia Peptide Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Peptide Consumption by Types from 2014 to 2026

    • Table Switzerland Peptide Consumption Share by Types from 2014 to 2026

    • Table Switzerland Peptide Consumption by End-Users from 2014 to 2026

    • Table Switzerland Peptide Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Peptide Consumption by Types from 2014 to 2026

    • Table Turkey Peptide Consumption Share by Types from 2014 to 2026

    • Table Turkey Peptide Consumption by End-Users from 2014 to 2026

    • Table Turkey Peptide Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptide Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Peptide Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Peptide Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Peptide Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Peptide Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Peptide Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptide Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptide Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptide Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptide Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptide Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptide Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Peptide Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Peptide Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Peptide Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptide Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptide Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptide Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptide Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptide Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptide Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Peptide Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Peptide Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Peptide Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Bachem

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bachem

    • Figure Sales and Growth Rate Analysis of Bachem

    • Figure Revenue and Market Share Analysis of Bachem

    • Table Product and Service Introduction of Bachem

    • Table Company Profile and Development Status of Xinbang

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Xinbang

    • Figure Sales and Growth Rate Analysis of Xinbang

    • Figure Revenue and Market Share Analysis of Xinbang

    • Table Product and Service Introduction of Xinbang

    • Table Company Profile and Development Status of USVPeptides

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of USVPeptides

    • Figure Sales and Growth Rate Analysis of USVPeptides

    • Figure Revenue and Market Share Analysis of USVPeptides

    • Table Product and Service Introduction of USVPeptides

    • Table Company Profile and Development Status of PolyPeptide

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PolyPeptide

    • Figure Sales and Growth Rate Analysis of PolyPeptide

    • Figure Revenue and Market Share Analysis of PolyPeptide

    • Table Product and Service Introduction of PolyPeptide

    • Table Company Profile and Development Status of JPT

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JPT

    • Figure Sales and Growth Rate Analysis of JPT

    • Figure Revenue and Market Share Analysis of JPT

    • Table Product and Service Introduction of JPT

    • Table Company Profile and Development Status of ScinoPharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ScinoPharm

    • Figure Sales and Growth Rate Analysis of ScinoPharm

    • Figure Revenue and Market Share Analysis of ScinoPharm

    • Table Product and Service Introduction of ScinoPharm

    • Table Company Profile and Development Status of Hybio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hybio

    • Figure Sales and Growth Rate Analysis of Hybio

    • Figure Revenue and Market Share Analysis of Hybio

    • Table Product and Service Introduction of Hybio

    • Table Company Profile and Development Status of Thermofischer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermofischer

    • Figure Sales and Growth Rate Analysis of Thermofischer

    • Figure Revenue and Market Share Analysis of Thermofischer

    • Table Product and Service Introduction of Thermofischer

    • Table Company Profile and Development Status of CPC Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CPC Scientific

    • Figure Sales and Growth Rate Analysis of CPC Scientific

    • Figure Revenue and Market Share Analysis of CPC Scientific

    • Table Product and Service Introduction of CPC Scientific

    • Table Company Profile and Development Status of Europe Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Europe Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Europe Pharmaceutical

    • Figure Revenue and Market Share Analysis of Europe Pharmaceutical

    • Table Product and Service Introduction of Europe Pharmaceutical

    • Table Company Profile and Development Status of GL Biochem

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GL Biochem

    • Figure Sales and Growth Rate Analysis of GL Biochem

    • Figure Revenue and Market Share Analysis of GL Biochem

    • Table Product and Service Introduction of GL Biochem

    • Table Company Profile and Development Status of Lanthio Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lanthio Pharma

    • Figure Sales and Growth Rate Analysis of Lanthio Pharma

    • Figure Revenue and Market Share Analysis of Lanthio Pharma

    • Table Product and Service Introduction of Lanthio Pharma

    • Table Company Profile and Development Status of New England Peptide

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of New England Peptide

    • Figure Sales and Growth Rate Analysis of New England Peptide

    • Figure Revenue and Market Share Analysis of New England Peptide

    • Table Product and Service Introduction of New England Peptide

    • Table Company Profile and Development Status of Genscript

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genscript

    • Figure Sales and Growth Rate Analysis of Genscript

    • Figure Revenue and Market Share Analysis of Genscript

    • Table Product and Service Introduction of Genscript

    • Table Company Profile and Development Status of AnaSpec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AnaSpec

    • Figure Sales and Growth Rate Analysis of AnaSpec

    • Figure Revenue and Market Share Analysis of AnaSpec

    • Table Product and Service Introduction of AnaSpec

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US